Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Otsuka Pharmaceutical Development & Commercialization, Inc.: treatNOW Abilify Physician Sample Kits Recalled for Mislabeling

Agency Publication Date: October 3, 2018
Share:
Sign in to monitor this recall

Summary

Otsuka Pharmaceutical Development & Commercialization, Inc. is recalling 22,063 physician sample kits of treatNOW Abilify (aripiprazole) and Abilify Maintena (aripiprazole) due to significant labeling errors. The product name is misspelled on the packaging, critical storage instructions are missing, and the contents of the kits may be incorrectly identified on the outer carton. These kits were distributed nationwide across the United States as physician samples and are marked as 'not for sale.'

Risk

The lack of proper storage instructions and incorrect identification of kit contents could lead to improper handling of the medication or confusion regarding the dosage and components. This poses a risk of administering the medication incorrectly or using a product that has lost its effectiveness due to improper storage.

What You Should Do

  1. Check your physician sample kit for the name 'treatNOW ABILIFY' or 'treatNOW ABILIFY / ABILIFY MAINTENA 400-mg' and look for barcodes DCSKit-59148-10Tabs-01 or VialKit-59148-10Tabs-02.
  2. For Pre-filled Dual Chamber Syringe Kits (Recall D-0017-2019), check for lot numbers 7F92YUD3H1A/AIS1017B or 7F92YUD3H1A/AIS1017C with an expiration date of 30-Jun-2020.
  3. For Vial Kits (Recall D-0018-2019), check for lot numbers 7F92YUD3H1A/ACS1616B (Exp 31-Jul-2019) or F92YUD3H1A/ACS0118C (Exp 30-Jun-2020).
  4. Contact your healthcare provider or pharmacist immediately for guidance if you have one of these mislabeled kits.
  5. Return any unused physician sample kits to the clinic or pharmacy where they were received for a refund or replacement instructions.
  6. Contact Otsuka Pharmaceutical at their Princeton, New Jersey headquarters for further information regarding this voluntary recall.
  7. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional assistance or to report any adverse effects.

Your Remedy Options

💰Full Refund

Healthcare provider consultation and pharmacy return

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG Pre-filled Dual Chamber Syringe Kit
Model:
DCSKit-59148-10Tabs-01
Lot Numbers:
7F92YUD3H1A/AIS1017B (Exp 30-Jun-2020)
7F92YUD3H1A/AIS1017C (Exp 30-Jun-2020)
Date Ranges: Expiration 30-Jun-2020
Product: treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) Vial Kit
Model:
VialKit-59148-10Tabs-02
Lot Numbers:
7F92YUD3H1A/ACS1616B (Exp 31-Jul-2019)
F92YUD3H1A/ACS0118C (Exp 30-Jun-2020)
Date Ranges: Expiration 31-Jul-2019, Expiration 30-Jun-2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 81020
Status: Resolved
Manufacturer: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sold By: Physician offices; Otsuka America Pharmaceutical, Inc.; Lundbeck
Manufactured In: United States
Units Affected: 2 products (17325 kits; 4738 kits)
Distributed To: Nationwide
Agency Last Updated: October 12, 2018

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.